Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Leukemia Initiating Cells In Acute Lymphoblastic Leukemia Are Characterized By Low Metabolic Activity and Enriched In Early Cell Cycle

Luca Trentin, PhD, Manon Queudeville, MD, Sarah M Eckhoff, MD, Manuel Herrmann, Simone Miller, Sandra Lutz, Nabiul Hasan, Klaus-Michael Debatin, MD PhD, Lueder H Meyer, MD PhD

Blood (2013) 122 (21): 4197.

https://doi.org/10.1182/blood.V122.21.4197.4197

Published: 2013

Journal Articles

Overcoming Apoptosis Resistance In High Risk Acute Lymphoblastic Leukemia By Smac Mimetics In a Preclinical ALL Xenograft Model In Vivo

Melanie Schirmer, MD, Manon Queudeville, MD, Luca Trentin, PhD, Sarah M Eckhoff, MD, Lueder H Meyer, MD, PhD, Klaus-Michael Debatin, MD, PhD

Blood (2013) 122 (21): 1433.

https://doi.org/10.1182/blood.V122.21.1433.1433

Published: 2013

Journal Articles

Rapid BCP-ALL Engraftment in NOD/SCID Mice Is Characterized by a High Leukemia Initiating Cell (LIC) Frequency.

Luca Trentin, PhD, Manon Queudeville, MD, Sarah M. Eckhoff, MD, Felix Seyfried, Manuel Herrmann, Simone Miller, Nabiul Hasan, Klaus-Michael Debatin, MD, PhD, Lueder H. Meyer, MD

Blood (2012) 120 (21): 2985.

https://doi.org/10.1182/blood.V120.21.2985.2985

Published: 2012

Journal Articles

Activation of Acute Lymphocytic Leukemia Blasts with CpG ODN, IL-4 and CD40 Ligand Facilitates Enhanced Anti-Leukemic CTL Responses

Dorit Fabricius, Lucia Breckerbohm, Manon Queudeville, MD, Angelika Vollmer, Sarah M. Eckhoff, MD, Johanna Pfeil, Gudrun Strauss, PhD, Simone Fulda, MD, Bernd Jahrsdoerfer, MD, Lueder H Meyer, MD, Klaus-Michael Debatin, MD

Blood (2010) 116 (21): 3907.

https://doi.org/10.1182/blood.V116.21.3907.3907

Published: 2010

Journal Articles

Single-Cell Phospho-Profiling in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia Reveals Signaling Differences in Cytogenetic and Prognostic Subgroups.

Manon Queudeville, MD, Sarah M. Eckhoff, MD, Klaus-Michael Debatin, MD, Lueder H. Meyer, MD

Blood (2009) 114 (22): 2653.

https://doi.org/10.1182/blood.V114.22.2653.2653

Published: 2009

Journal Articles

Xenografts of Pediatric Acute Lymphoblastic Leukemia Retain the Gene Expression Pattern From the Diagnostic Material They Originated From Over Serial Passages.

Manon Queudeville, MD, Elena Vendramini, Marco Giordan, PhD, Sarah M. Eckhoff, MD, Giuseppe Basso, MD, Klaus-Michael Debatin, MD, Truus Te Kronnie, PhD, Lueder H. Meyer, MD

Blood (2009) 114 (22): 1629.

https://doi.org/10.1182/blood.V114.22.1629.1629

Published: 2009

Journal Articles

Deficient Apoptosis Signaling in Primary Pediatric BCP-ALL Xenograft Cells Determines the Kinetic of Engraftment in Vivo in a NOD/SCID Model and Patient Outcome

Manon Queudeville, MD, Sarah M. Eckhoff, MD, Karsten Stahnke, MD, Klaus-Michael Debatin, MD, Lueder H. Meyer, MD

Blood (2008) 112 (11): 2509.

https://doi.org/10.1182/blood.V112.11.2509.2509

Published: 2008

Journal Articles

Single-Cell Phospho-Profiling in Pediatric Acute Lymphoblastic Leukemia (ALL) Reveals Constitutive and Cytokine Induced Specific Signatures Involving Stat5

Manon Queudeville, MD, Hannah Kunze, Sarah M. Eckhoff, MD, Klaus-Michael Debatin, MD, Lueder H. Meyer, MD

Blood (2008) 112 (11): 2511.

https://doi.org/10.1182/blood.V112.11.2511.2511

Published: 2008

Journal Articles

Time to Leukemia (TTL) in NOD/SCID Mice Determines Patient Outcome and Is Characterized by a 5 Genes Signature Associated with Relapse

Lueder Hinrich Meyer, MD, Andrea Zangrando, PhD, Sarah M. Eckhoff, MD, Manon Queudeville, MD, Elena Vendramini, Giuseppe Basso, MD, Geertruy te Kronnie, PhD, Klaus-Michael Debatin, MD

Blood (2008) 112 (11): 755.

https://doi.org/10.1182/blood.V112.11.755.755

Published: 2008

Journal Articles

Time to Leukaemia (TTL) Assessed in NOD/SCID Mice Transplanted with Primary ALL Leukaemia Cells Determines Early Relapse in Patients and Is Identified by a Specific Gene Signature.

Lüder H. Meyer, MD, Sarah M. Eckhoff, MD, Manon Dammé, Martin Zimmermann, PhD, André Schrauder, MD, Georgia Lahr, PhD, Karsten Stahnke, MD, Martin Schrappe, MD, Klaus M. Debatin, MD

Blood (2007) 110 (11): 726.

https://doi.org/10.1182/blood.V110.11.726.726

Published: 2007

Journal Articles

Favourable Treatment Outcome in Childhood AML Is Determined by Intact Apoptosis Signalling in Myeloid Leukaemia Cells.

Lüder H. Meyer, MD, Manon Dammé, Sarah M. Eckhoff, MD, Ursula Creutzig, MD, Dirk Reinhardt, MD, Leonid Karawajew, PhD, Wolf D. Ludwig, MD, Karsten Stahnke, MD, Klaus M. Debatin, MD

Blood (2007) 110 (11): 2842.

https://doi.org/10.1182/blood.V110.11.2842.2842

Published: 2007

NARROW

Leukemia Initiating Cells In Acute Lymphoblastic Leukemia Are Characterized By Low Metabolic Activity and Enriched In Early Cell Cycle

Overcoming Apoptosis Resistance In High Risk Acute Lymphoblastic Leukemia By Smac Mimetics In a Preclinical ALL Xenograft Model In Vivo

Rapid BCP-ALL Engraftment in NOD/SCID Mice Is Characterized by a High Leukemia Initiating Cell (LIC) Frequency.

Activation of Acute Lymphocytic Leukemia Blasts with CpG ODN, IL-4 and CD40 Ligand Facilitates Enhanced Anti-Leukemic CTL Responses

Single-Cell Phospho-Profiling in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia Reveals Signaling Differences in Cytogenetic and Prognostic Subgroups.

Xenografts of Pediatric Acute Lymphoblastic Leukemia Retain the Gene Expression Pattern From the Diagnostic Material They Originated From Over Serial Passages.

Deficient Apoptosis Signaling in Primary Pediatric BCP-ALL Xenograft Cells Determines the Kinetic of Engraftment in Vivo in a NOD/SCID Model and Patient Outcome

Single-Cell Phospho-Profiling in Pediatric Acute Lymphoblastic Leukemia (ALL) Reveals Constitutive and Cytokine Induced Specific Signatures Involving Stat5

Time to Leukemia (TTL) in NOD/SCID Mice Determines Patient Outcome and Is Characterized by a 5 Genes Signature Associated with Relapse

Time to Leukaemia (TTL) Assessed in NOD/SCID Mice Transplanted with Primary ALL Leukaemia Cells Determines Early Relapse in Patients and Is Identified by a Specific Gene Signature.

Favourable Treatment Outcome in Childhood AML Is Determined by Intact Apoptosis Signalling in Myeloid Leukaemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only